Financials EQUINOX NEPREMICNINE d.d.

Equities

EQNX

SI0031117813

Real Estate Development & Operations

End-of-day quote Ljubljana S.E. 18:00:00 2024-05-26 EDT 5-day change 1st Jan Change
54.5 EUR 0.00% Intraday chart for EQUINOX NEPREMICNINE d.d. +5.83% +3.81%

Valuation

Fiscal Period: December 2023 2024 2025 2026
Capitalization 1 94.18 97.59 - -
Enterprise Value (EV) 1 94.18 97.59 97.59 97.59
P/E ratio 109 x - - -
Yield - 4.84% 4.83% 5.1%
Capitalization / Revenue - 11.2 x 10.9 x 10.3 x
EV / Revenue - 11.2 x 10.9 x 10.3 x
EV / EBITDA - 14.4 x 14 x 13.3 x
EV / FCF - 14.6 x 24 x 21.1 x
FCF Yield - 6.86% 4.17% 4.74%
Price to Book - - - -
Nbr of stocks (in thousands) 1,794 1,791 - -
Reference price 2 52.50 54.50 54.50 54.50
Announcement Date 1/15/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2023 2024 2025 2026
Net sales 1 - 8.706 8.986 9.466
EBITDA 1 - 6.773 6.959 7.345
EBIT 1 - 3.726 3.786 3.945
Operating Margin - 42.8% 42.13% 41.68%
Earnings before Tax (EBT) - - - -
Net income 0.8691 - - -
Net margin - - - -
EPS 0.4800 - - -
Free Cash Flow 1 - 6.692 4.069 4.623
FCF margin - 76.87% 45.28% 48.84%
FCF Conversion (EBITDA) - 98.8% 58.47% 62.94%
FCF Conversion (Net income) - - - -
Dividend per Share 2 - 2.640 2.630 2.780
Announcement Date 1/15/24 - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2023 2024 2025 2026
Net Debt - - - -
Net Cash position - - - -
Leverage (Debt/EBITDA) - - - -
Free Cash Flow 1 - 6.69 4.07 4.62
ROE (net income / shareholders' equity) - - - -
ROA (Net income/ Total Assets) - - - -
Assets - - - -
Book Value Per Share - - - -
Cash Flow per Share - - - -
Capex 1 - 0.5 2.3 2.3
Capex / Sales - 5.74% 25.6% 24.3%
Announcement Date 1/15/24 - - -
1EUR in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
54.5 EUR
Average target price
63.5 EUR
Spread / Average Target
+16.51%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. EQNX Stock
  4. Financials EQUINOX NEPREMICNINE d.d.